Gradual Application from Discovery to Optimization of Candidate Substances
Office Operations Expected to Reduce Task Time by Up to 90 Percent
Physical AI to Be Introduced at New API Plants 4 and 5

On May 26, Celltrion announced that it will introduce artificial intelligence (AI) into its three core work areas: new drug development, manufacturing, and office operations. Through AI Transformation (AX), the company aims to automate repetitive tasks and enhance its global competitiveness.


Celltrion Introduces AI to New Drug Development, Manufacturing, and Office Operations... Launches Two-Track AX Strategy View original image

Currently, the most active application of AI is in new drug development. Last year, Celltrion established a dedicated AI-based new drug development team and has been gradually applying AI to the discovery, validation, and optimization of new drug target candidates using bioinformatics (BI) and AI technologies. As a result, the company expects to dramatically shorten the typical development period, which usually takes more than 10 years, and significantly reduce costs. For internal researchers, 'reskilling' programs are being conducted to strengthen data analysis and AI utilization capabilities, and the company is building its pipeline through open innovation with external AI specialists.


In the manufacturing sector, the focus is on implementing smart factories utilizing physical AI, particularly at newly established plants. Celltrion plans to increase automation levels at its planned new active pharmaceutical ingredient (API) plants 4 and 5 in Songdo by adopting autonomous mobile robots (AMRs), automated logistics warehouses, intelligent robotic arms and collaborative robots, and manufacturing management software. Until the plants are completed, the company will automate standardized operations, and afterwards, it will expand AI applications to include high value-added decision-making tasks to further improve production efficiency. In the long term, depending on the maturity of the technology, humanoid robots will also be introduced to achieve unmanned operation of unstructured, high-difficulty tasks.


For office operations, AI is currently being used for data analysis, dashboard creation, and insight generation, with plans to gradually expand its scope. In particular, simulations applying chatbots to the company’s electronic document management system (EDMS) have shown that the time required for simple tasks such as document searches and comparisons could be reduced by approximately 80 to 90 percent compared to previous methods.


Celltrion’s AX strategy is implemented through a two-track approach combining bottom-up efforts by on-site employees and top-down initiatives at the company-wide level. Employees are not limited to simply using AI platforms; each department directly implements automation tools, while at the company level, experts participate in developing and applying AI-based specialized systems for tasks such as document creation and yield optimization.


Through this strategy, Celltrion plans to encourage proactive AI utilization in the field, establish differentiated systems for each business process, and achieve not only short-term improvements in work convenience but also medium- to long-term results by maximizing AI utilization across the entire business.


Meanwhile, the company reported that after conducting AI utilization training earlier this year, an internal survey showed that average employee satisfaction with AI usage exceeded 90 percent.



A Celltrion official stated, "The AI technologies we are fully implementing from this year are substantially broadening the scope of work automation and continuously improving work efficiency," and added, "From new drug development to every stage of our business, we aim to become a global, comprehensive pharmaceutical company with a complete AI value chain."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing